Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

77.67EUR
11:35am EDT
Change (% chg)

€1.09 (+1.42%)
Prev Close
€76.58
Open
€77.01
Day's High
€78.01
Day's Low
€76.84
Volume
571,355
Avg. Vol
881,161
52-wk High
€81.08
52-wk Low
€46.69

FMEG.DE

Chart for FMEG.DE

About

Fresenius Medical Care AG & Co KGaA is a Germany-based kidney dialysis company that operates in the fields of dialysis care and dialysis products for the treatment of end-stage renal disease (ESRD). Its dialysis business is vertically integrated and offers products and services for the entire dialysis value chain, providing... (more)

Overall

Beta: 0.21
Market Cap(Mil.): €23,830.55
Shares Outstanding(Mil.): 311.19
Dividend: 0.78
Yield (%): 1.02

Financials

  FMEG.DE Industry Sector
P/E (TTM): 31.01 24.51 40.78
EPS (TTM): 2.47 -- --
ROI: 6.18 7.09 16.19
ROE: 10.81 21.27 17.04
Search Stocks

Fitch Revises Fresenius' Outlook to Stable; Affirms at 'BB+'

(The following statement was released by the rating agency) LONDON, March 19 (Fitch) Fitch Ratings has revised Fresenius Medical Care AG & Co. KGaA's (FMC) and Fresenius SE & Co. KGaA's (FSE, consolidated 'Fresenius') Outlook to Stable from Positive. Its Long- and Short-term Issuer Default Ratings (IDRs) have been affirmed at 'BB+' and 'B', respectively. Please see below for a detailed list of rating actions. Although Fresenius' business risk profile has improved, with its scale, profitabil

19 Mar 2015

FMC sees opportunities in care coordination in Europe

FRANKFURT, Feb 25 - Dialysis provider Fresenius Medical Care is eyeing Europe as a place to take a first step into so-called care coordination businesses outside its main market North America.

25 Feb 2015

Fresenius Medical Care sees strong profit growth in 2016

FRANKFURT - Kidney dialysis specialist Fresenius Medical Care forecast strong profit growth in 2016 after more modest progress this year while it cuts costs to counter pressures on payments for treatment in the United States and moves into new healthcare services.

25 Feb 2015

UPDATE 3-Fresenius Medical Care sees strong profit growth in 2016

* FMC sees forex-adjusted net income growth of 0-5 pct in 2015

25 Feb 2015

Fresenius Medical Care says profit may not grow until 2016

FRANKFURT, Feb 25 - German kidney dialysis specialist Fresenius Medical Care (FMC) said net income could be flat this year but would grow again in 2016, as it cuts costs to counter pressure in the United States on reimbursement for dialysis treatments.

25 Feb 2015

Fresenius sheds 'junk' credit rating for first time

FRANKFURT, Jan 19 - German healthcare group Fresenius, the owner of Europe's largest private-sector hospitals chain, received investment-grade status from a ratings agency for the first time, after recent acquisitions have spread its business risks.

19 Jan 2015

China halts anti-dumping probe into EU, Japan dialysis kit makers

SHANGHAI - China has halted an anti-dumping investigation into European and Japanese makers of blood dialysis equipment, ending a six-month probe that had extended to the Chinese market leader, Germany's Fresenius Medical Care (FMC) AG & Co KGaA.

16 Dec 2014

China halts anti-dumping probe into EU, Japan dialysis kit makers

SHANGHAI, Dec 17 - China has halted an anti-dumping investigation into European and Japanese makers of blood dialysis equipment, ending a six-month probe that had extended to the Chinese market leader, Germany's Fresenius Medical Care (FMC) AG & Co KGaA.

16 Dec 2014

BRIEF-Fresenius Medical Care refinances, extends credit

* Says upsizes and extends maturity of its credit agreement

27 Nov 2014

Fresenius Medical takes over U.S. healthcare group Cogent

FRANKFURT - Germany's Fresenius Medical Care said it agreed to take over Cogent Healthcare, a U.S. provider of specialist physicians to hospitals, as part of its drive to offer additional services linked to its core business of kidney dialysis.

13 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Pechala's Reports
$15.00
Provider: Finlabo SIM Spa
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks